Metraipolis › archive › dc_188e9231cc98

Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic — Europe PMC PMID:37579382

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37579382
DOI
10.34172/ijhpm.2023.6936
License (as archived)
solo-consultazione
Archived
2026-10-07T12:19:53.942Z
SHA-256 of the archived text
fe18fcf601eb96d188d6b3da48b8980ef4d2e1fafe449f2261a0ad24fe546719
Stable URL of this page
https://metraipolis.com/documento/dc_188e9231cc98

How to cite

Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic — Europe PMC PMID:37579382 — Europe PMC (en), https://europepmc.org/article/MED/37579382 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_188e9231cc98 (Metraipolis archive dc_188e9231cc98, sha256 fe18fcf601eb96d188d6b3da48b8980ef4d2e1fafe449f2261a0ad24fe546719)
BibTeX
@misc{dc188e9231cc98,
  title = {Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic — Europe PMC PMID:37579382},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37579382},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_188e9231cc98; sha256 fe18fcf601eb96d188d6b3da48b8980ef4d2e1fafe449f2261a0ad24fe546719},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/37579382. Agents can read the archived copy with the MCP tool read_document.